Neal Young

Credentials: · ·

History

Immune Pathophysiology of Aplastic Anemia and Immunosuppressive Treatments
National Heart, Lung, and Blood Institute · ZIA
Contact PI · $60.1M · National Heart, Lung, and Blood Institute
Telomere Diseases and Other Constitutional and Acquired Genetic Disorders of Hematopoiesis
National Heart, Lung, and Blood Institute · ZIA
Contact PI · $26.2M · National Heart, Lung, and Blood Institute
Pathogenesis And Treatment Of Aplastic Anemia
National Heart, Lung, and Blood Institute · Z01
Contact PI · $9.5M · National Heart, Lung, and Blood Institute
Viruses and Hematopoiesis
National Heart, Lung, and Blood Institute · ZIA
Contact PI · $4.1M · National Heart, Lung, and Blood Institute

Eltrombopag With Standard Immunosuppression for Severe Aplastic Anemia
Principal investigator · Active not recruiting · Phase 1, Phase 2
National Heart, Lung, and Blood Institute (NHLBI)
2012–2029
Danazol for Genetic Bone Marrow and Lung Disorders
Principal investigator · Completed · Phase 1, Phase 2
National Heart, Lung, and Blood Institute (NHLBI)
2011–2016
A Pilot Study of a Thrombopoietin-Receptor Agonist, Eltrombopag, in Patients With Low to Int-2 Risk Myelodysplastic Syndrome (MDS)
Principal investigator · Completed · Phase 2
National Heart, Lung, and Blood Institute (NHLBI)
2011–2021
Screening Protocol for Subjects Being Evaluated for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI) Protocols
Principal investigator · Completed
National Heart, Lung, and Blood Institute (NHLBI)
2009–2017